Finch Therapeutics Group, Inc. Common Stock
FNCH
FNCH was delisted on the 24th of May, 2024.
36 hedge funds and large institutions have $109M invested in Finch Therapeutics Group, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
+$20.5M |
| 2 |
BL
Bleichroeder LP
New York
|
+$13.8M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$12.2M |
| 4 |
TA
TRB Advisors
New York
|
+$9.34M |
| 5 |
AI
Aperture Investors
New York
|
+$7.97M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
26
CAAS Capital Management
New York
| $323K | +$340K | +667 | New |
|
27
Norges Bank
Oslo,
Norway
| $318K | +$340K | +667 | New |
|
28
Wellington Management Group
Boston,
Massachusetts
| $293K | +$313K | +614 | New |
|
|
BFM
29
Boothbay Fund Management
New York
| $284K | +$298K | +586 | New |
|
30
Tudor Investment Corp
Stamford,
Connecticut
| $279K | +$293K | +575 | New |
|
|
PHK
31
Point72 Hong Kong
Hong Kong
| $239K | +$252K | +494 | New |
|
|
MS
32
Maven Securities
St Helier,
Jersey
| $185K | +$201K | +395 | New |
|
33
HighTower Advisors
Chicago,
Illinois
| $181K | +$191K | +374 | New |
|
34
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $51K | +$54K | +106 | New |
|
35
Point72 Asset Management
Stamford,
Connecticut
| $23K | +$24.4K | +48 | New |
|
|
PSB
36
Piscataqua Savings Bank
Portsmouth,
New Hampshire
| $6K | +$6.62K | +13 | New |
|
FNCH Hedge Fund Activity: Q1 2021 in Review
36 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Finch Therapeutics Group, Inc. Common Stock (FNCH) for Q1 2021, worth a combined $109M.
Buyers outnumbered sellers: 36 funds opened new FNCH positions and 0 closed out — a net gain of 36 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Baupost Group, opening a new position worth an estimated $20.5M.
- 36 institutional investors held Finch Therapeutics Group, Inc. Common Stock (FNCH) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $109M of Finch Therapeutics Group, Inc. Common Stock stock for Q1 2021.
- 36 funds opened new Finch Therapeutics Group, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +36 holders.
- The largest Finch Therapeutics Group, Inc. Common Stock buyer in Q1 2021 was Baupost Group, an estimated $20.5M added.
Based on aggregated 13F filings for Q1 2021.